Back to Results

Neonc Technologies Holdings Inc (NTHI)

NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) is a clinical-stage biopharmaceutical company focused on developing therapies for intracranial malignancies. The company’s pipeline includes NEO100, a purified form of perillyl acid that is being evaluated in a Phase IIa clinical trial, and NEO212, a conjugated compound combining temozolomide and perillyl alcohol that is being studied in Phase I/II trials for oral use in primary brain cancers. Target indications mentioned in the source include meningioma, high-grade gliomas, glioblastoma, and secondary brain cancers. Founded in 2005 and headquartered in Calabasas, California, the company was previously known as NAS-ONC, Inc. before adopting its current name in 2009.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-NTHI
$4.80
47.4% Upside
Undervalued
$16
390.8% Upside
Bargain
Weak
0.0%
November 13, 2026
2,026.3x
81.033 M
82.522 M
0.4%
32.3%
-71.9
44.8%
Valuation • Fair Value

Neonc Technologies Holdings Inc (NASDAQ-NTHI) Fair Value by Valuation Model

Review the available estimates for Neonc Technologies Holdings Inc (NASDAQ-NTHI), including Comps Fair Value.

Primary Valuation Read

Fair Value

$4.80

Estimated upside of 47.4% versus the current market price.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

Comps Fair Value

$4.80

Comparable-company valuation reference.

Analyst Price Target

$16

Analysts imply upside of 390.8%.

How to read these valuation models

Use the 4 available valuation references for Neonc Technologies Holdings Inc (NASDAQ-NTHI) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Neonc Technologies Holdings Inc (NASDAQ-NTHI)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

39.99 K

Current operating scale indicator.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Neonc Technologies Holdings Inc (NASDAQ-NTHI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Neonc Technologies Holdings Inc (NASDAQ-NTHI)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

4

Mid-range quality score.

Altman Z-Score

-71.9

Lower score that deserves closer risk review.

FCF / Net Income

44.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Neonc Technologies Holdings Inc (NASDAQ-NTHI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Neonc Technologies Holdings Inc (NASDAQ-NTHI)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 13, 2026

Days to Earnings

56

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Neonc Technologies Holdings Inc (NASDAQ-NTHI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Neonc Technologies Holdings Inc (NASDAQ-NTHI) Stock Forecast & Technical Outlook

Review Neonc Technologies Holdings Inc (NASDAQ-NTHI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Neonc Technologies Holdings Inc (NASDAQ-NTHI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Neonc Technologies Holdings Inc (NASDAQ-NTHI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Neonc Technologies Holdings Inc (NASDAQ-NTHI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Neonc Technologies Holdings Inc (NASDAQ-NTHI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Neonc Technologies Holdings Inc (NASDAQ-NTHI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Neonc Technologies Holdings Inc (NASDAQ-NTHI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Neonc Technologies Holdings Inc (NASDAQ-NTHI) has a Strong Buy consensus, with 2 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 0
Sell 0
FAQ • Fast Investor Answers

Neonc Technologies Holdings Inc (NASDAQ-NTHI) Stock FAQ

Data-supported answers about Neonc Technologies Holdings Inc (NASDAQ-NTHI), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$4.80
Estimated upside 47.4%
Valuation Rating
Undervalued
Estimated upside of 47.4%
Analyst Target
$16
Implied upside 390.8%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Neonc Technologies Holdings Inc (NASDAQ-NTHI) is $4.80. This implies an estimated upside of 47.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 47.4% versus the current market price.

The available analyst price target for Neonc Technologies Holdings Inc (NASDAQ-NTHI) is $16. The analyst target implies estimated upside of 390.8%.

The current financial health read for Neonc Technologies Holdings Inc (NASDAQ-NTHI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Neonc Technologies Holdings Inc (NASDAQ-NTHI) is November 13, 2026.

The latest available data indicates no current dividend yield for Neonc Technologies Holdings Inc (NASDAQ-NTHI).

The current market capitalization listed for Neonc Technologies Holdings Inc is 81.033 M.

The current enterprise value listed for Neonc Technologies Holdings Inc is 82.522 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Neonc Technologies Holdings Inc is NASDAQ-NTHI, and the stock is listed on NASDAQ.

Neonc Technologies Holdings Inc (NASDAQ-NTHI) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Neonc Technologies Holdings Inc is 0.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Neonc Technologies Holdings Inc is 32.3%. Free float helps investors understand how much of the share base is available for public trading.

Similar Pharmaceuticals Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

LLY NYSE Eli Lilly and Company Fair Value Fair Market Cap 1,027.7 B
JNJ NYSE Johnson & Johnson Fair Value Fair Market Cap 650.6 B
MRK NYSE Merck & Company Inc Fair Value Fair Market Cap 362.4 B
NVS NYSE Novartis AG ADR Fair Value Fair Market Cap 266.2 B
NVO NYSE Novo Nordisk A/S Fair Value Bargain Market Cap 191.3 B
PFE NYSE Pfizer Inc Fair Value Fair Market Cap 157.7 B
BMY NYSE Bristol-Myers Squibb Company Fair Value Fair Market Cap 128.8 B
SNY NASDAQ Sanofi ADR Fair Value Undervalued Market Cap 101.9 B
GSK NYSE GSK plc DRC Fair Value Undervalued Market Cap 100.8 B
TAK NYSE Takeda Pharmaceutical Co Ltd ADR Fair Value Fair Market Cap 60.801 B
TEVA NYSE Teva Pharma Industries Ltd ADR Fair Value Fair Market Cap 45.423 B
HLN NYSE HALEON PLC ADR Fair Value Fair Market Cap 40.198 B
RPRX NASDAQ Royalty Pharma Plc Fair Value Fair Market Cap 33.653 B
ZTS NYSE Zoetis Inc Fair Value Bargain Market Cap 29.504 B
VTRS NASDAQ Viatris Inc Fair Value Undervalued Market Cap 19.446 B
JAZZ NASDAQ Jazz Pharmaceuticals PLC Fair Value Fair Market Cap 15.628 B
CORT NASDAQ Corcept Therapeutics Incorporated Fair Value Fair Market Cap 11.943 B
ELAN NYSE Elanco Animal Health Fair Value Fair Market Cap 11.202 B
AXSM NASDAQ Axsome Therapeutics Inc Fair Value Fair Market Cap 10.884 B
RDY NYSE Dr. Reddy’s Laboratories Ltd ADR Fair Value Fair Market Cap 10.161 B